Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab (Q38817006)
Jump to navigation
Jump to search
scientific article published on 27 April 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab |
scientific article published on 27 April 2017 |
Statements
1 reference
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab (English)
1 reference
Diabetic Retinopathy Clinical Research Network
1 reference
Adam R Glassman
1 reference
Lee M Jampol
1 reference
Susan B Bressler
1 reference
Danni Liu
1 reference
Barbara A Blodi
1 reference
Alessandro A Castellarin
1 reference
Paul L Kaufman
1 reference
Michele Melia
1 reference
Harinderjit Singh
1 reference
John A Wells
1 reference
1 June 2017
1 reference
1 reference
135
1 reference
558-568
1 reference
6
1 reference
1 reference
Identifiers
1 reference
1 reference